omidenepag isopropyl

omidenepag isopropyl (OMLONTI) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

OMLONTI is a marketed brand name for omidenepag isopropyl. Check FDA Drugs@FDA for the current US label holder and prescribing information.

omidenepag isopropyl has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.